A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
Public ClinicalTrials.gov record NCT06499285. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Elritercept (KER-050) for the Treatment of Transfusion-Dependent Anemia in Adult Participants With Very Low-, Low-, or Intermediate-Risk Myelodysplastic Syndromes (MDS) (RENEW)
Study identification
- NCT ID
- NCT06499285
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Takeda
- Industry
- Enrollment
- 225 participants
Conditions and interventions
Conditions
Interventions
- Elritercept Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 5, 2025
- Primary completion
- Apr 30, 2028
- Completion
- Apr 30, 2032
- Last update posted
- May 12, 2026
2025 – 2032
United States locations
- U.S. sites
- 23
- U.S. states
- 13
- U.S. cities
- 23
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| City of Hope | Duarte | California | 91010 | Recruiting |
| Los Angeles Cancer Network | Glendale | California | 91206 | Recruiting |
| UC San Diego Moores Cancer Center | La Jolla | California | 92037 | Recruiting |
| Smilow Cancer Hospital at Yale-New Haven | New Haven | Connecticut | 06511 | Recruiting |
| University of Miami Hospital and Clinics | Miami | Florida | 33136 | Recruiting |
| Moffitt Cancer Center | Tampa | Florida | 33612 | Recruiting |
| ILCC. Illinois Cancer Centers | Peoria | Illinois | 61645 | Not yet recruiting |
| Norton Cancer Institute | Louisville | Kentucky | 40207 | Recruiting |
| Maryland Oncology Hematolofy | Columbia | Maryland | 21044 | Recruiting |
| MidAmerica Cancer Care | Kansas City | Missouri | 64132 | Not yet recruiting |
| Comprehensive Cancer Centers of Nevada | Henderson | Nevada | 89169 | Recruiting |
| Northwell Health | Lake Success | New York | 11042 | Not yet recruiting |
| Clinical Research Alliance NY | Westbury | New York | 11590 | Not yet recruiting |
| Novant Health-Cancer Institute | Winston-Salem | North Carolina | 27013 | Not yet recruiting |
| Gabrail Cancer Center Research | Canton | Ohio | 44718 | Recruiting |
| Cleveland Clinic - Cleveland | Cleveland | Ohio | 44195 | Recruiting |
| Tennessee Cancer Specialists | Knoxville | Tennessee | 37909 | Recruiting |
| Baptist Clinical Research Institute | Memphis | Tennessee | 38120 | Not yet recruiting |
| Vanderbilt University Medical Center | Nashville | Tennessee | 37232 | Recruiting |
| Texas Oncology Northeast Texas | Denison | Texas | 75020 | Not yet recruiting |
| U.T. MD Anderson Cancer Center, Division of Cancer Medicine | Houston | Texas | 77030 | Recruiting |
| Texas Oncology Gulf Coast | The Woodlands | Texas | 77380 | Recruiting |
| Tranquil Research | Webster | Texas | 77598-4085 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 156 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06499285, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 12, 2026 · Synced May 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06499285 live on ClinicalTrials.gov.